|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 215/227 | (2006.01) |
| C07D 401/12 | (2013.01) | ||
| C07D 215/46 | (2006.01) | ||
| C07D 413/04 | (2013.01) | ||
| A61K 31/4375 | (2013.01) | ||
| A61K 31/4706 | (2006.01) | ||
| A61K 31/506 | (2013.01) | ||
| C07D 401/04 | (2006.01) | ||
| C07D 401/12 | (2006.01) | ||
| A61K 31/496 | (2013.01) | ||
| C07D 401/14 | (2006.01) | ||
| C07D 215/46 | (2013.01) | ||
| C07D 405/04 | (2006.01) | ||
| A61K 31/5377 | (2013.01) | ||
| C07D 405/14 | (2006.01) | ||
| C07D 409/14 | (2013.01) | ||
| C07D 409/14 | (2006.01) | ||
| A61P 31/12 | (2018.01) | ||
| C07D 413/04 | (2006.01) | ||
| A61K 31/4706 | (2013.01) | ||
| C07D 413/12 | (2006.01) | ||
| C07D 215/227 | (2013.01) | ||
| C07D 405/04 | (2013.01) | ||
| C07D 413/14 | (2006.01) | ||
| C07D 417/14 | (2006.01) | ||
| C07D 471/08 | (2013.01) | ||
| C07D 471/04 | (2006.01) | ||
| A61K 31/4709 | (2013.01) | ||
| C07D 487/08 | (2006.01) | ||
| A61K 31/5386 | (2013.01) | ||
| C07D 498/04 | (2006.01) | ||
| A61K 31/497 | (2013.01) | ||
| A61P 29/00 | (2006.01) | ||
| C07D 417/12 | (2013.01) | ||
| C07D 498/08 | (2013.01) |
| (11) | Number of the document | 3511323 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18201850.7 |
| Date of filing the European patent application | 2014-03-12 | |
| (97) | Date of publication of the European application | 2019-07-17 |
| (45) | Date of publication and mention of the grant of the patent | 2022-03-02 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201361781583 P | 2013-03-14 | US | |
| 201361882798 P | 2013-09-26 | US |
| (72) |
AMANS, Dominique , GB
ATKINSON, Stephen John , GB
HARRISON, Lee Andrew , GB
HIRST, David Jonathan , GB
LAW, Robert Peter , GB
LINDON, Matthew , GB
PRESTON, Alexander , GB
SEAL, Jonathan Thomas , GB
WELLAWAY, Christopher Roland , GB
|
| (73) |
GlaxoSmithKline Intellectual Property (No.2)
Limited ,
980 Great West Road
Brentford, Middlesex, TW8 9GS,
GB
|
| (54) | 2,3-DISUBSTITUTED 1-ACYL-4-AMINO-1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES AND THEIR USE AS BROMODOMAIN INHIBITORS |
| 2,3-DISUBSTITUTED 1-ACYL-4-AMINO-1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES AND THEIR USE AS BROMODOMAIN INHIBITORS |